Radioiodine therapy is a type of targeted treatment used primarily for certain types of thyroid cancer. It involves the use of radioactive iodine (I-131) to destroy cancerous thyroid cells. This therapy leverages the thyroid gland's natural ability to absorb iodine, thus concentrating the radioactive material in the thyroid tissue, including cancerous cells.
